More possible dilution | IMGN Message Board Posts

ImmunoGen, Inc.

  IMGN website

IMGN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  51166 of 51408  at  9/26/2020 7:28:10 PM  by

Biotechbeagle

The following message was updated on 9/26/2020 7:30:33 PM.

 In response to msg 51165 by  MRHIROLLER
view thread

Re: More possible dilution

Well Jefferies last price target back in August was $4.

Jefferies analyst Biren Amin lowered the price target on Immunogen Inc. (NASDAQ: IMGN) to $4.00 (from $4.50) while maintaining a Hold rating.

Since they have selected a dose and schedule for imgn 632 and have plans to move into a phase 2b, then data must be good enough to continue on. Only question is could they get a fast track for BPDCN? Iím sure they will wait for that event to raise money. I suspect that and IMGN936 being a first in class have to move the stock price.




     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 385
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
51167 Re: More possible dilution jv08201 1 9/27/2020 11:48:48 AM






Financial Market Data provided by
.
Loading...